ThomasRichardKostenMD

Psychiatry • Houston, TX

Addiction

Director, Division of Alcohol and Addiction Psychiatry, Baylor College of Medicine

Join to view full profile

Dr. Kosten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kosten's full profile

Already have an account?

Office
2002 Holcombe Blvd
Va Bldg 110, Room 229
Houston, TX 77030
Phone+1 713-794-7032

Education & Training

Yale UniversityM.A., 1995
Yale-New Haven Medical CenterFellowship, Addiction Psychiatry, 1983 - 1983
Yale-New Haven Medical CenterFellowship, Addiction Psychiatry, 1981 - 1983
Yale-New Haven Medical CenterResidency, Psychiatry, 1978 - 1981
Yale-New Haven Medical CenterInternship, Transitional Year, 1977 - 1978
Weill Cornell MedicineClass of 1977
Rensselaer Polytechnic InstituteB.S., Biophysics, 1973

Certifications & Licensure

TX State Medical License 2007 - 2024
CT State Medical License 1979 - 2023
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Distinguished Life Fellow American Psychiatric Association (APA), 2014
Research Career Award American Psychiatric Association (APA), 2011
Research Career Award Spanish Psychiatric Association (SPA), 2011
Best Doctors in America, Addiction Psychiatry 2009
Founder’s Award American Academy of Addiction Psychiatry, 2008
Best Doctors in America 2008
60th Diamond Edition of Who’s Who in America 2005
America’s Top Doctors, 1st – Current Edition America’s Top Doctors, 2002
Top Doctors, New York Metro Area 5th-9th Editions 2001
Nyswander Award for Research in Opiate Dependence American Methadone Treatment Association, 2000
Senior Scientist Award National Institute on Drug Abuse (NIDA), 2000
Distinguished Fellow American Psychiatric Association (APA), 1996
Joel Elkes International Award for Outstanding Contributions to Psychopharmacology American College of Neuropsychopharmacology (ACNP), 1993
Joseph Cochin Award, Research in Substance Abuse Committee on Problems of Drug Dependence (CPDD), ReChartered Committee of National Academy of Science (NAS), 1990
Research Scientist Development Award NIDA, 1987
Deithelem Prize for Excellence in Psychiatry Cornell University, 1977
Fellow in Biophysics National Science Foundation, 1972
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Buprenorphine Maintenance for Opioid Addicts - 1 Start of enrollment: 1988 Aug 01
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 2 Start of enrollment: 1988 Aug 01
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 3 Start of enrollment: 1988 Aug 01
Completed
Phase 2
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 Start of enrollment: 1994 Sep 01
Terminated
Phase 1
Mazindol for Cocaine Abuse - 2 Start of enrollment: 1994 Sep 01
Completed
Phase 2
Disulfiram for Cocaine-Alcohol Abuse - 3 Start of enrollment: 1994 Sep 01
Completed
Phase 2
Novel Medications for Opiate Detoxification - 4 Start of enrollment: 1994 Sep 01
Completed
Phase 2
Glutaminergic Agents for Cocaine Abuse - 5 Start of enrollment: 1994 Sep 01
Completed
Phase 1
Pharmacotherapy for Schizophrenic Drug Users - 6 Start of enrollment: 1994 Sep 01
Completed
Phase 2
Pemoline for Cocaine Abuse - 7 Start of enrollment: 1994 Sep 01
Completed
Phase 2
Effectiveness of TA-CD Vaccine in Treating Cocaine Dependent Individuals Start of enrollment: 2003 Jul 01
The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 Start of enrollment: 2004 Sep 01
Terminated
Not Applicable
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts Start of enrollment: 2006 Feb 01
Completed
Phase 2
Therapeutic Cocaine Vaccine for Cocaine Dependent Individuals Start of enrollment: 2003 Sep 01
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1 Start of enrollment: 2003 Mar 01
Completed
Phase 1
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia Start of enrollment: 2006 Nov 01
Completed
Phase 3
Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD) Start of enrollment: 2008 Jun 01
Withdrawn
Phase 2
The Efficacy of Doxazosin for Cocaine Users Start of enrollment: 2009 Sep 01
Completed
Phase 1
Multisite Controlled Trial of Cocaine Vaccine Start of enrollment: 2010 Aug 01
Completed
Phase 2
Pharmacogenetics of Doxazosin for Cocaine Dependence Start of enrollment: 2010 Mar 01
Completed
Phase 2
A Pilot Study of Candesartan as a Treatment for Cocaine Dependence Start of enrollment: 2013 Jan 01
Terminated
Phase 2
Entolimod, an Adjuvant for Vaccine Augmentation Start of enrollment: 2017 Dec 08
Completed
Early Phase 1
Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study) Start of enrollment: 2021 Nov 01
Completed
Phase 1
Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans Start of enrollment: 2021 Mar 09
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'.
Marco Pappagallo, Thomas R Kosten, Charles W Gorodetzky, Frank J Vocci, Frank L Sapienza
Molecular Psychiatry. 2024-12-01
Transcranial Direct Current Stimulation Combined With Repetitive Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial.
Dongsheng Zhou, Xingxing Li, Shuochi Wei, Chang Yu, Dongmei Wang
JAMA Network Open. 2024-11-04
Biological Insights from Schizophrenia-associated Loci in Ancestral Populations.
Tim B Bigdeli, Chris Chatzinakos, Jaroslav Bendl, Peter B Barr, Sanan Venkatesh
Medrxiv. 2024-08-28

Journal Articles

The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic
Thomas R Kosten, Ismene L Petrakis, JAMA Psychiatry
Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury
Thomas R Kosten, David P Graham, JAMA
Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms
An HM, Tan YL, Shi J, Wang ZR, Li J, Wang YC, Lv MH, Zhou DF, Soares JC, Kosten TR, Yang FD, Zhang XY, Behav Brain Res, 1/1/2016
Cocaine Addictions Vaccine
Kosten TR, Thematic Meeting on Addictions, 1/28/2015
Evolving Strategies for Substance Use Disorders
Kosten TR, North American Center for Continuing Medical Education (NACCME), 1/14/2015
New Anti-Addiction Medications: Pharmacogenetics and Immunotherapies
Kosten TR, North American Center for Continuing Medical Education (NACCME), 1/12/2015
[Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach
Krupitskii EM, Kibitov AO, Blokhina EA, Verbitskaia EV, Brodianskii VM, Alekseeva NP, Bushara NM, Iaroslavtseva TS, Palatkin VI, Masalov DV, Burakov AM, Romanova TN, S..., Zh Nevrol Psikhiatr Im S S Korsakova, 1/1/2015
Extensive white matter abnormalities and clinical symptoms in first episode and drug-naive schizophrenia: a voxel-based diffusion tensor imaging study
Zhang XY, Chen DC, Fan FM, Tan YL, Tan SP, Hu K, Salas R, Kosten TR, Zunta-Soares G, Soares JC, Journal of Clinical Psychiatry, 1/1/2015
Addictions
Kosten TR, American Society of Clinical Psychopharmacology, 1/22/2014
New Anti-Addiction Medications: Pharmacogenetics and Immunotherapies
Kosten TR, 27th Annual U.S. Psychiatric & Mental Health Congress Conference, 1/20/2014
Internet Addiction: Compulsive Internet Use
Kosten TR, Advances in Clinical Psychiatr: Addictive Behaviors, 1/10/2014
Pharmacogenetics of Cocaine: Disulfiram and Vaccines
Kosten TR, American Academy of Addiction Psychiatry Annual Meeting, 1/5/2014
A national survey of clinicians’ views of evidence-based therapies for PTSD and substance abuse
Najavits LM, Kivlahan D, Kosten T, Addiction Research & Theory, 1/1/2011
Rounsaville MD: 1949-2011
Kosten T, Bruce J, Drug and Alcohol Dependence, 1/1/2011
Drug Abuse Criminal Sentencing for Crack Cocaine
Kosten TR, U.S. Senate Judiciary Committee, 1/1/2009
Sex- and age-dependent effects of early postnatal sibling deprivation on spatial learning and memory in adult rats
Li YQ, Wang XY, Zhai HF, Zhang XY, Kosten T, Lu L, Behav Brain Res, 1/1/2008
Vaccines for Addiction
Kosten TR, U.S. Congressional Testimony, 1/1/2008
Anti-addiction vaccines
Kosten, Thomas R, Contrastes, 1/1/2007
Pharmacotherapeutic Environments for Substance Use Disorders
Gardner TG, Kosten TR, American Journal of Drugs and Alcohol Abuse, 1/1/2007
Brain-derived neurotrophic factor polymorphisms and smoking in schizophrenia
Wang ZR, Zhou DF, Cao LY, Tan YL, Zhang XY, Li J, Lu L, Wu GY, Kosten TA, Kosten TR, Schizophr Res, 1/1/2007
Substance Use in OIF/OEF Veterans Substance Use Disorder (SUD) QUERI Initiatives
Calhoun P, Najavits LM, Kosten T, Kivlahan D, VA Health Services Research & Devlopment Forum, 1/1/2007
Buprenorphine for opiate dependence
Kosten TR, U.S. Senate testimony, 1/1/2006
Welcome to a New Editorial Generation
Kosten, TR, American Journal of Drugs and Alcohol Abuse, 1/1/2006
Cue-induced brain activity changes and treatment outcome in depressed cocaine dependent patients
Kosten TR, Scanley BE, Tucker K, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE, Neuropsychopharmacology, 1/1/2006
Advances in pharmacotherapy of stimulant dependence: From alcohol antagonists to Xenova vaccines
Kosten TR, Clinical Neuroscience Research, 1/1/2005
Join now to see all

Books/Book Chapters

Psychiatry
Chapter: General Approaches to Substance Use Disorders
Kosten, TR. and Domingo CEditors: A. Tasman, J. Kay, J. A. Lieberman, M. B. First and M. B. Riba.John Wiley & Sons, Ltd, Chichester, UKEdition 4th,2015
Biologics to Treat Substance Use Disorders
Chapter: Vaccines for Treating Cocaine Use Disorders
Domingo CB, Shorter D, and Kosten TREditors: Montoya ID.Springer International Publishing, Bethesda, MD2015
Biologics to Treat Substance Use Disorders
Chapter: Vaccines for Methamphetamine Use Disorder
Kosten TR, Kosten TAEditors: Montoya ID.Springer International Publishing, Bethesda, MD2015
The ASAM Essentials of Addiction Medicine
Chapter: The Pharmacology of Nicotine and Tobacco
Domingo CB, Kosten TREditors: A. Herron.Lippincot, Williams & WilkinsEdition 2nd,2014
Case Series DSM-V
Chapter: Stress and Substance Abuse
Jin L, Shorter D, Domingo C, Kosten TREditors: J. Barnhill.Edition 1st,2013
Cocaine and Methamphetamine Dependence: Advances in Treatment
Thomas R. Kosten, Thomas F. Newton, Richard De La Garza II, Colin N. HaileAmerican Psychiatric Publishing, Arlington, VA2012
Encyclopedia of Behavioral Neuroscience
Chapter: Comorbidity-Depression
Page 308 - 316Kosten TR, Davis DEEditors: Koob GF, Le Moal M, Thompson RF.Academic Press, Oxford, UK2010
Principles of Addiction Medicine
Chapter: Nicotine and Tobacco: Pharmacology
Dani JA, Kosten TR, Benowitz NEditors: Ries, Fiellin, Miller, Saitz.Lippincott Williams & Wilkins2009
Conn’s Current Therapy
Chapter: Anxiety disorders
Teng E, Kosten TREditors: Rakel RE.W.B. Saunders Company, Philadelphia, PA2009
Cambridge Textbook of Effective Treatments in Psychiatry
Chapter: Treatment of Stimulant Dependence
Page 369 - 380Sofuoglu M, Agath K, Kosten TREditors: Tyrer P, Silk K.Cambridge University Press2008
Encyclopedia of Drugs, Alcohol and Addictive Behaviors
Chapter: Treatment, pharmacological approaches to: Buprenorphine
Gardner T, Kosten TR2008
Treatments of Psychiatric Disorder
Chapter: Stimulants and Related Drugs: Substance-Related Disorders
Page 265 - 269Kosten TR, Sofuoglu M, Weaver MF, Schnoll SH, Pbert LA, Ockene JKEditors: GO Gabbard.American Psychiatric PublishingEdition 4th,2007
Introduction to addictive behaviors. Substance Abuse Series
Thombs DLEditors: Blane HT, Kosten TR, (Series Editors).Guilford Press, New York, NYEdition 3rd,2006
Substance Abuse: A Comprehensive Textbook
Chapter: Detoxification
Page 579 - 587Chang G, Kosten TREditors: Lowinson JH, Ruiz P, Millman RB, Langrod JG.Lippincott Williams & Wilkins, Philadelphia, PAEdition 4th,2005
Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don’t Know
Chapter: Substance Use Disorders
Page 335 - 426O’Brien CP, Anthony JC, Carroll K, Childress AR, Dackis C, Diamond G, Hornik R, Johnston LD, Jones R, Koob GF, Kosten T, Lerman C, McLellan AT, Moss H, Pettinati H, S...Editors: Evans DL, Foa EB, Gur RE, Hendin H, O’Brien CP, Seligman MEP, Walsh BT.Oxford University Press, New York, NY2005
Clinical Manual of Addiction Psychopharmacology
Chapter: Cocaine and psychostimulants
Page 183 - 209Kosten TREditors: Kranzler HR, Ciraulo DA.American Psychiatric Publishing Inc., Washington, DC2005
Clinical Textbook of Addictive Disorders
Chapter: The Neurobiology of Substance Dependence: Implications for Treatment
Page 3 - 15Kosten TR, George T, Kleber HDEditors: Frances R, Miller S, Mack AH.Guilford Publications, New York, NY2005
Clinical Textbook of Addictive Disorders
Chapter: Psychopharmacological treatments
Page 588 - 614McCance EF, Kosten TREditors: Frances R, Miller S.Guilford Publications, New York, NYEdition 3rd,2005
Rethinking Substance Abuse: What the Science Shows and What We Should Do About It
Chapter: Pharmacotherapy of addictive disorders
Page 240 - 256O’Malley S, Kosten TREditors: Miller WR & Carroll KM.Guilford Press, New York, NY2005
Clinical work with substance –abusing clients. Substance Abuse Series
Kosten TREditors: Blane HT, Kosten TR, (Series Editors), Straussner SLA, ed.Guilford Press, New York, NYEdition 2nd,2004
DSM-V Treatment Case Book
Chapter: Opiate dependence treatment
Kosten TREditors: Spitzer R.American Psychiatric Press, Inc., Washington, DC2004
Problems of Drug Dependence 2003: Proceedings of the 65th Annual Scientific Meeting, The College on Problems of Drug Dependence
Chapter: Immunotherapies for substance abuse (Symposium III)
Page 31 - 33Owens M, Pentel P, Kosten TREditors: Dewey WL.Bethesda, MD2004
New Treatments for Addiction: Behavioral, Ethical, Legal and Social Questions
Chapter: What will we learn from the FDA clinical trials process and what will we still want to know about immunotherapies and depot medications to treat drug dependence
Page 98 - 124Kosten, TR, Kranzler HEditors: Harwood HJ, Myers TG.The National Academies Press, Washington, DC2004
Principles of Addiction Medicine
Chapter: Pharmacologic interventions for opioid addiction
Page 735 - 748Stine SM, Greenwald MK, Kosten TREditors: Graham AW, Schultz TK, Mayo-Smith M, Ries RK & Wilford BB.American Society of Addiction Medicine, Chevy Chase, MDEdition 3rd,2004
Maintenance Treatment of Heroin Addiction -Evidence at the Crossroads
Chapter: Evidence for the choice between methadone, LAAM and buprenorphine
Page 108 - 120Kosten TREditors: Waal H. & Haga E.Cappelen Akademisk Forlag, Oslo, Norway2003
Join now to see all

Lectures

Cocaine and Methamphetamine: Pharmacology to Pipeline Treatments
Anaheim, CA - 1/3/2014
Vaccines for Addictions
Houston, TX - 1/9/2013
Ethical Issues Related to Agonist Therapy for Opoid Addictions
Houston, TX - 1/9/2013
Addictions Pharmacotherapy
Dallas, TX - 1/30/2012
Vaccines for Cocaine and Methamphetamine Addictions
Boston, MA - 1/17/2012
Pharmacogenetics of Cocaine Vaccine
Beijing, China - 1/17/2012
Vaccine and Behavioral Approaches to U.S. Health Disparities: Sexually Transmitted Infections (STI) and Addiction
National Harbor, MD - 1/12/2012
Addiction Vaccines
Houston, TX - 1/12/2012
Genetic & Immunological Predictors of Treatment Response: Alcohol and Cocaine
Galveston, TX - 1/11/2012
Cocaine Vaccine: Genetic Predictors of Treatment Response
Palm Springs, CA - 1/9/2012
Stimulant Addiction
San Francisco, CA - 1/5/2012
Medication Development for Stimulant Dependence
Marina Del Rey, CA - 1/1/2012
Genetics of the Cocaine Vaccine Response
Beijing, China - 1/27/2011
Advances in Vaccines for Treating Substance Dependence
Beijing, China - 1/21/2011
Genetics and Biological Markers in Addictions and Dual Disorders
Barcelona, Spain - 1/5/2011
202X Trends and Perspectives – Goals, Governance, Innovation, Immunization Strategy
Philadelphia, PA - 1/2/2011
Pharmacogenitics of Cocaine
Beijing, China - 1/16/2010
Behavior, Biology, and Chemistry, Translational Research in Addiction
San Antonio, TX - 1/1/2009
The Neurobiology & Pharmacotherapy of Stimulant Dependence
Houston, TX - 1/11/2008
Psychopharmacology, Innovations in Pharmacotherapy of Substance Abuse
Houston, TX - 1/31/2007
Depression in Addictions: Suicide in Adolescents
1/30/2007
Vaccines and other pharmacological alternatives in the treatment of cocaine addiction
Barcelona, Spain - 1/27/2007
The psychopathology and treatment of addiction; Preclinical and clinical aspects of vaccination for addiction
Shanghai, China - 1/20/2007
Addressing depression in opioid-maintained patients
Prague, Czech Republic - 1/19/2007
Affective dysfunction in substance abuse
Quebec, Canada - 1/17/2007
Join now to see all

Other

Emerging Treatments and Pharmacogenetics for Cocaine Use Disorder
Andry, T. N., Shorter, D., & Kosten, T. R
http://www.psychiatrictimes.com/substance-use-disorder/emerging-treatments-and-pharmacogenetics-cocaine-use-disorder?GUID=5F1CDC00-0422-41BF-A817-C5DC23E2BB33&rememberme=1&ts=06062016
1/31/2016
Black Box Warning and Pain Killers
Kosten TR, Fox News, Channel 26 News Interview
Houston, TX - 1/24/2016
Pharmacotherapy for Adults with Alcohol Use Disorder (AUD) in Outpatient Settings
Achanta, A., Kosten, T. R., & Fordis, M
http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=2161
1/16/2016
Medicines to Treat Alcohol Use Disorder: A Review of the Research for Adults
Smith, A. W., Kosten, T. R., & Fordis, M
http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=2162
1/16/2016
Alcohol Use Disorders
Kosten TR, Indivior Pharmaceuticals
New York, NY - 1/1/2016
NIDA Notes: How Will Anti-Drug Vaccines be Used
Kosten TR
https://www.drugabuse.gov/news-events/nida-notes/podcasts/2015/05/dr-thomas-kosten
1/29/2015
Personalized Medicine Is Coming to Addiction Treatment
Kosten TR
http://www.substance.com/personalized-medicine-is-coming-to-addiction-treatment/18824/
1/15/2015
A “Hands-On” Guide to Using Naltrexone in Alcohol Addictions
Kosten TR
http://r.search.yahoo.com/_ylt=A0SO8zi2fORWh84A9JVXNyoA;_ylu=X3oDMTEycTJlODhxBGNvbG8DZ3ExBHBvcwMyBHZ0aWQDQjE3MjVfMQRzZWMDc3I-/RV=2/RE=1457843511/RO=10/RU=http%3a%2f%2fwww.psychiatrictimes.com%2fprintpdf%2f203288/RK=0/RS=Dun8PGY6_faxklGuzpf0YIPXZ6g
1/12/2015
NIDA Notes: Vaccines to Treat Addiction
Kosten TR
https://www.drugabuse.gov/news-events/nida-notes/2015/06/dr-thomas-kosten-q-vaccines-to-treat-addiction
1/11/2015
When is Internet Use and Gaming Addictive?
Kosten TR, Menninger Mindscape Podcast
http://www.youtube.com/watch?v=VB952PxJ11M&feature=youtu.be
Houston, TX - 1/29/2014
Substance Abuse
Kosten TR, WWL 870AM/105.3FM
http://media.wwl.com/a/94548946/7-16-14-12-10pm-garland-on-substance-abuse.htm?q=kosten
1/16/2014
Cocaine Vaccine Reaches Therapeutic Levels, Improves Treatment Retention And Abstinence Rates, But Does Not Decrease Overall Cocaine Use
Kosten TR, Baylor College of Medicine
http://abclocal.go.com/ktrk/story?section=news/health&id=8980325
1/5/2014
Pharmacogenetics to Predict Treatment Outcome in Substance Use Disorders
Kosten TR
http://www.psychiatrictimes.com/AAAP2014/pharmacogenetics-predict-treatment-outcome-substance-use-disorders#sthash.h2XlzG7k.dpuf.
1/4/2014
How a Vaccine Could Halt Heroine Addiction
Kosten TR, Minnesotta Public Radio (MPR)
http://www.mprnews.org/story/2014/06/02/daily-circuit-heroin-vaccine
1/2/2014
High Blood Pressure Drug May Help Cocaine Dependence
Kosten TR, MED Houston VA Medical Center
1/23/2013
Stimulating Big Pharma to Invest in Medications for Stimulant Addiction
Kosten TR, SameFacts.com
http://www.samefacts.com/2012/11/drug-policy/stimulating-big-pharma-to-invest-in-medications-for-stimulant-addiction/
1/26/2012
A Vaccine to Curb Addicts’ Highs
Kosten TR, Wall Street Journal
http://online.wsj.com/article/SB10001424127887324352004578130963934871462.html
1/23/2012
Avoiding Addiction When It’s In Your DNA
Kosten TR
http://www.pbs.org/newshour/updates/science/july-dec12/milesaddiction.html
1/13/2012
Unregulated Bath Salts Drugs Becoming More Dangerous
Kosten TR, Channel 2-Houston
http://www.click2houston.com/news/Unregulated-bath-salts-drug-becoming-more-dangerous/-/1735978/14470270/-/e1lu03/-/index.html
1/4/2012
Antidrug Vaccines
Kosten TR, Psychiatric Times
http://www.psychiatrictimes.com/articles/antidrug-vaccines
1/19/2011
High on Cocaine
Kosten TR, National Geographic
http://channel.nationalgeographic.com/channel/drugged/galleries/episode-high-on-cocaine/
1/16/2011
A Vaccine for Cocaine Addiction? Rx in the City
Kosten TR
http://houston.culturemap.com/newsdetail/07-07-11-a-vaccine-for-cocaine-addiction-baylor-college-of-medicines-dr-thomas-kosten-is-almost-there/
1/7/2011
Quest for Vaccines to Treat Addictions
Kosten TR, Wallstreet Journal
http://online.wsj.com/article/SB10001424052748704436004576298980739463392.html
1/3/2011
Shots Help Fight Cocaine Addiction
Kosten TR
http://abclocal.go.com/ktrk/story?section=news/health&id=7049306
1/5/2009
A Drug to End Drug Addiction
Kosten TR
http://www.time.com/time/health/article/0,8599,1701864,00.html
1/9/2008
Join now to see all

Authored Content

Innovative Non-Opioids for Chronic Pain: Cannabidiol and KetamineOctober 2019
Innovative Non-Opioids for Chronic Pain: Cannabidiol and KetamineOctober 2019

Press Mentions

Heroin Antibody Fares Better Than Earlier Therapies That Targeted Its MetabolitesNovember 1st, 2022
Exhibition: ‘The Human Cost: America’s Drug Plague’ at the Bronx Documentary Center, New YorkJune 13th, 2021
$25 Million NIH Grant Funds Adjuvant Opioid Use Disorder VaccineApril 21st, 2021
Join now to see all

Grant Support

Multisite Controlled Trial Of Cocaine Vaccine (1of 6) LEAD Site/ Houston TreatmenNational Institute On Drug Abuse2008–2012
Human Methamphetamine Vaccine: Translational Avante Garde AwardNational Institute On Drug Abuse2011
Stimulant Pharmacotherapy: Noradrenergic TargetsNational Institute On Drug Abuse2009–2011
Methadone StudiesNational Institute On Drug Abuse2009–2011
Clinical Methods CoreNational Institute On Drug Abuse2009–2011
Kappa Opioid Antagonist For Cocaine AddictionNational Institute On Drug Abuse2005–2011
Developing Immunotherapeutics For Methamphetamine AbuseNational Institute On Drug Abuse2009–2010
Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse2006–2010
Tropisetron With Risperidone For SchizophreniaNational Institute Of Mental Health2007–2009
Administrative And Scientific CoreNational Institute On Drug Abuse2007–2008
Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse2006–2008
Pharmacotherapies Of Cocaine Addiction In HumansNational Institute On Drug Abuse2007
Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse2006–2007
Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse2005
Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse2004–2005
Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse2004–2005
Scientific And Administrative CoreNational Institute On Drug Abuse2004
Cocaine Vaccine For Methadone Maintained PatientsNational Institute On Drug Abuse2002–2004
Pharmacotherapy For Opioid And Cocaine DependenceNational Institute On Drug Abuse2001–2004
Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse2000–2004
Cocaine Pharmacotherapies For Comorbid PopulationsNational Institute On Drug Abuse1999–2003
FMRI Of Gender And Stress Response In Cocaine DependenceNational Institute On Drug Abuse2002
Therapeutic Cocaine VaccineNational Institute On Drug Abuse2000–2002
Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse2000–2002
Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse2000–2002
Core--Medication Development Research CenterNational Institute On Drug Abuse1999–2002
Clopidogrel &Isradipine For Brian Perfusion Defects In Cocaine AbusersNational Institute On Drug Abuse1999–2002
11th - 15th Annual Meetings And SymposiaNational Institute On Drug Abuse2000–2001
Buprenorphine Maintenance For Opioid AddictsNational Institute On Drug Abuse1988–2000
9th/13th Annual Meeting And SymposiumNational Institute On Drug Abuse1998–1999
Clinical Research Center For Opioid And Cocaine AbuseNational Institute On Drug Abuse1991–1999
Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse1997–1998
Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse1997–1998
Core--CoreNational Institute On Drug Abuse1996–1998
Yale Medications Development Research CenterNational Institute On Drug Abuse1994–1998
Non-Opioid Neurobiology Of Opioid DependenceNational Institute On Drug Abuse1996–1997
Cocaine Discrimination In Humans--Effects Of Dopaminergic AgentsNational Institute On Drug Abuse1996–1997
Agonist To Antagonist--New ApproachesNational Institute On Drug Abuse1994–1995
Reducing AIDS RisksNational Institute On Drug Abuse1994
Matching Methadone Patients To Psychosocial TreatmentNational Institute On Drug Abuse1993–1994
Small Instrumentation GrantNational Institute On Drug Abuse1993
Treatment Research Unit--Reducing AIDS RisksNational Institute On Drug Abuse1989–1993
Agonist To Antagonist: New ApproachesNational Institute On Drug Abuse1987–1993
The Yale University Substance Abuse Research CenterNational Institute On Drug Abuse1991
Pharmacotherapy Of IV Cocaine Use In Methadone PatientsNational Institute On Drug Abuse1987–1989

Professional Memberships

American College of Neuropsychopharmacology
Fellow
American Psychiatric Association - APA
Distinguished Life Fellow
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY
PAST PRESIDENT & DISTINGUISHED FELLOW
College on problems of drug dependence
Past President and Distinguished Fellow